BAY94-9027
15912
Phase 3 mab completed
Quick answer
BAY94-9027 for Hemophilia A is a Phase 3 program (mab) at Bayer HealthCare AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer HealthCare AG
- Indication
- Hemophilia A
- Phase
- Phase 3
- Modality
- mab
- Status
- completed